PROF. DR. HANY BINTI MOHD ARIFFIN
Department of Paediatrics
Faculty of Medicine
hanyum.edu.myView CV | |
View 1-Page CV | |
Publons | |
Scopus Link | |
Biography | |
Professor Hany Ariffin is Professor of Paediatrics and Head of the Division of Paediatric Haematology-Oncology and Blood & Marrow Transplantation at the University of Malaya Medical Centre (UMMC). She also heads the Biobank Unit in the Faculty of Medicine, UM. Her main research interest is childhood leukaemia and she has been the Malaysian lead for the Malaysia-Singapore (MASPORE) Leukaemia Study Group since 2003. Her other research areas include childhood cancer survivorship, stem cell transplantation and inherited cancers, particularly related to mutations in the tumour suppressor gene, TP53. In 2015, she won the Anugerah Akademik Negara award and in 2018 received the Distinguished Researcher Award from University Malaya. Professor Hany is chairperson of the paediatric oncology accreditation committee for the National Specialist Register and a past president of the Malaysian Society of Paediatric Haematology-Oncology. She is also the chairperson of the VIVA-Asia Bone Marrow Transplantation Consortium for 2023/2024. As co-chair of the Asian Childhood Cancer Alliance, Professor Hany works with regional colleagues as well as StJude Children's Research Hospital to support the WHO Global Initiative for Childhood Cancer (WHO-GICC). The project's tagline is: “60 by 30” - which refers to the aim of reaching at least a 60% survival rate for children with cancer by 2030, thereby saving an additional one million lives around the world. Professor Hany has been a reviewer for many scientific journals and is currently an Associate Editor (Tumour Biology) for Technology in Cancer Reseach &Treatment.
|
Publication
Finance
Project Title | Progress | Status |
---|---|---|
Mechanistic Insights Into Wild-type P53 Activity In Childhood Cancers, Using In Silico Prediction And In Vitro Modelling |
|
end |
Maspore-all 2020: Improving Risk Assignment And Treatment Outcome In Childhood Acute Lymphoblastic Leukaemia Through Precision Medicine And Immunotherapy |
|
end |
Improving Survical Quality Of Childhood Cancer Via Safer And More Effective Hla-haploidentical Haemopioetic Stem Cell Transplantatio |
|
end |
This information is generated from Research Grant Management System |
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
Clinical and Economic Impact of CMV Infection in Allogeneic Hematopoietic Stem Cell Transplantation: Perspectives from a Middle-Income Nation
Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
Pediatric Picture Tests for Medical Students
Inherited Pediatric Cancer in Low- and Intermediate-Resource Countries
Leukemia and Lymphoma
Handbook of Hospital Pediatrics